Affiliation: Beijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Ophthalmology & Visual Sciences Key Laboratory, Beijing, 100730 China.

Dr. Jingxue Zhang received his MD & PhD in Ophthalmology from Capital Medical University in 2007. He is currently an associated professor in Beijing Tongren Eye Center at Capital Medical University. His research focuses on the clinical transformation of cutting-edge biotechnology in ophthalmology, mainly including the clinical transformation of gene therapy and stem cell therapy. He has carried out a clinical translational study of the human RPE cell transplantation on retinal neurodegenerative diseases, and proposed a "cocktail" gene therapy scheme combining synergistic intervention with exogenous ligands and receptors for retinal microenvironment regulation.He won the "Young Scholar Award" of the Asian-African Ophthalmology Association (2014). He Dr Zhang is currently the director general of the Youth Committee of the Chinese Ophthalmologist Association, and the vice president of the Youth Committee of the Beijing Ophthalmologist Association.